Does taking blood pressure medication at bedtime reduce heart attack and stroke risk?
The short answer is no — at least not for the average person. The largest and most recent randomized controlled trial on this question, the BedMed trial (2025), followed over 3,300 Canadian adults for a median of 4.6 years and found that taking all once-daily antihypertensives at bedtime versus in the morning produced nearly identical rates of death or hospitalization for stroke, heart attack, or heart failure: 2.3 events per 100 patient-years in the bedtime group versus 2.4 in the morning group [3]. This was a well-designed, pragmatic trial with blinded endpoint assessment, and it found no benefit — and no harm — from evening dosing. Safety outcomes like falls, fractures, and new glaucoma diagnoses also did not differ between groups [3].
These results overturn earlier, smaller studies that had suggested a bedtime advantage. The key takeaway: for most patients, the best time to take your blood pressure medication is the time you will remember to take it consistently. Medication adherence itself is far more important than the hour on the clock — a 2025 Korean study of nearly 240,000 people found that poor adherence dramatically increased the risk of death, heart attack, and stroke across all blood pressure levels, with the highest risk in those with both high systolic pressure (≥150 mmHg) and poor adherence [6].
But what if you are a night owl? Timing may matter for heart attack prevention.
While the overall timing of medication does not matter for most people, a 2024 sub-study of the TIME trial (which included over 5,300 participants) found that your personal chronotype — whether you are a morning person or a night owl — may influence how your body responds to dosing time [1]. Researchers measured chronotype using a validated questionnaire and found that later chronotypes (night owls) who took their blood pressure medication in the morning had a 46% higher risk of the composite cardiovascular endpoint (non-fatal heart attack or stroke) for each hour later their mid-sleep time fell. In contrast, night owls who dosed in the evening saw no such increase [1]. The effect was especially strong for heart attack: morning dosing in later chronotypes increased risk by 62% per hour of later sleep timing, while evening dosing actually reduced risk by 34% [1].
This finding suggests that synchronizing medication timing with your internal circadian rhythm — not just the clock on the wall — could lower heart attack risk. However, this was a sub-study, not a primary trial, and the overall TIME trial (which did not account for chronotype) found no difference between morning and evening dosing for the whole group. So while the evidence is promising, it is not yet strong enough to change guidelines for everyone. If you are a night owl, you might discuss with your doctor whether evening dosing could be right for you.
Are there situations where timing really does matter?
Yes — in specific clinical contexts, timing can be critical. For hospitalized patients, especially older veterans, using as-needed (PRN) blood pressure medications for asymptomatic high readings was linked to worse outcomes. A 2024 study of over 133,000 veterans found that those who received as-needed BP meds had a 23% higher risk of acute kidney injury, a 1.5-fold greater risk of rapid blood pressure drops, and a 69% higher rate of the composite of heart attack, stroke, or death during hospitalization [2]. The takeaway: in the hospital, reactive, as-needed dosing appears harmful compared to sticking with scheduled medications.
For patients on hemodialysis, a 2022 cluster-randomized trial found that taking blood pressure medications before dialysis (versus holding them) did not increase the risk of dangerously low blood pressure during the session, and it actually improved blood pressure control before dialysis [4]. So for dialysis patients, taking medications as prescribed — rather than holding them — appears safe and beneficial for hypertension management.
In acute stroke care, timing is everything. A 2025 study of 111 patients with intracerebral hemorrhage (a type of bleeding stroke) showed that meeting aggressive time targets — imaging within 30 minutes, blood pressure medication within 30 minutes of diagnosis, and transfer to a neuro ICU within 90 minutes — reduced mortality from 18.4% to 12.7% and cut 30-day readmissions from 12.9% to 3.2% [5]. For these patients, every minute counts.
About These Sources
This answer is built on 6 peer-reviewed studies — published from 2022 to 2025, 5 from 2024 or later, 5 in Q1 journals, collectively cited 61 times — selected as the most relevant from 12 studies that passed quality screening, drawn from 59 papers retrieved from a database of over 500 million.
Sources used in this answer
Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study
In a sub-study of the TIME trial (5,358 participants), later chronotype (night owls) who took antihypertensives in the morning had a 46% higher risk of cardiovascular events per hour of later sleep timing, while evening dosing eliminated that risk; the interaction was significant for heart attack but not stroke [1].
As-Needed Blood Pressure Medication and Adverse Outcomes in VA Hospitals
In a retrospective cohort of 133,760 hospitalized veterans, as-needed (PRN) blood pressure medication use was associated with a 23% higher risk of acute kidney injury, a 1.5-fold greater risk of rapid BP drop, and a 69% higher rate of heart attack, stroke, or death compared to non-users [2].
Antihypertensive Medication Timing and Cardiovascular Events and Death
In the BedMed pragmatic RCT (3,357 adults, median 4.6 years follow-up), bedtime vs. morning dosing of antihypertensives showed no difference in the primary composite outcome (death or hospitalization for stroke, heart attack, or heart failure): 2.3 vs. 2.4 events per 100 patient-years; safety outcomes also did not differ [3].
Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis: A Cluster Randomized Trial.
In a cluster-randomized trial of 131 hemodialysis patients, taking BP medications before dialysis was not noninferior to holding them for preventing intradialytic hypotension, but it did reduce uncontrolled hypertension (predialysis SBP >160 mmHg) by 15% [8].
Abstract TMP18: Establishing Aggressive Time Targets for the Identification and Treatment of Intracerebral Hemorrhage Improves Patient Outcomes
In a quality improvement study of 111 intracerebral hemorrhage patients, meeting aggressive time targets (imaging within 30 min, BP meds within 30 min, ICU transfer within 90 min) reduced mortality from 18.4% to 12.7% and 30-day readmissions from 12.9% to 3.2% [10].
Impact of blood pressure and medication adherence on clinical outcomes in patients with hypertension
In a Korean cohort of 238,950 hypertensive patients, higher systolic BP and poor medication adherence were independently associated with worse outcomes; those with SBP ≥150 mmHg and poor adherence had the highest risk of death, heart attack, or stroke [12].